MedPath
FDA Approval

Extended Phenytoin Sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
November 12, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Phenytoin(100 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aphena Pharma Solutions - Tennessee, LLC

Aphena Pharma Solutions - Tennessee, LLC

128385585

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Extended Phenytoin Sodium

Product Details

NDC Product Code
71610-479
Application Number
ANDA040765
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 12, 2020
PhenytoinActive
Code: 4182431BJHClass: ACTIBQuantity: 100 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath